Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...

Add Yahoo as a preferred source to see more of our stories on Google. For the first time, a breathing lung model has been made using cells from only one person. Announced on January 1, the development ...

When the team knocked out the P2Y2 receptor in drug-resistant cancer cells, it led to an almost complete loss of the mutant EGFR protein.

Lung diseases like tuberculosis and cystic fibrosis can be difficult to treat. In part, that's because the two-dimensional models researchers use to study the diseases don't accurately reflect the ...

Respiratory infections are among the leading causes of illness and death in the elderly, driven by immune aging, chronic ...

For the first time, a breathing lung model has been made using cells from only one person. Announced on January 1, the development comes from researchers at the Francis Crick Institute in London and ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...